Complement C3 vs C5 inhibition in severe COVID-19 early clinical findings reveal differential biological efficacy
Dimitrios C. Mastellos Bruno Garcia Peixoto Pires da Silva; Benedito Antonio Lopes da Fonseca; Natasha Peixoto Fonseca; Maria Auxiliadora Martins; Sara Mastaglio; Annalisa Ruggeri; Marina Sironi; Peter Radermacher; Akrivi Chrysanthopoulou; Panagiotis Skendros; Konstantinos Ritis; Ilenia Manfra; Simona Iacobelli; Markus Huber-Lang; Bo Nilsson; Despina Yancopoulou; E. Sander Connolly; Cecilia Garlanda; Fabio Ciceri; Antonio M Risitano; Rodrigo Tocantins Calado; John D Lambris
Clinical Immunology Maryland Heights v. 220, art. 108598, 2020
Maryland Heights 2020
Localização:
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 3029634 Acervo Digital )(Acessar)